Pfizer, Allergan terminate merger after U.S. targets tax loophole

Wednesday, April 6, 2016 - 06:30 in Earth & Climate

Andrew V. PestanoWASHINGTON, April 6 (UPI) -- Pfizer and Allergan have abandoned a $152 billion merger due to U.S. government actions attempting to close a tax loophole known as corporate inversions.

Read the whole article on UPI

More from UPI

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net